The exercise price was DKK 224.40 per share for 7,917 of new shares and DKK 90.70 per share for 19,508 of new shares. The total proceeds to Zealand Pharma from the capital increase amount to DKK 3,545 ...

Sovereign Pharma, a leader in high-quality injectable manufacturing, proudly announces its milestone: EU approval for aseptic and terminally sterilized products, including vials, ampoules, cartridges, ...

Speaking at the India-New Zealand Economic Forum, New Zealand Prime Minister Christopher Luxon expressed confidence in the trade ministers’ ability to fast-track the agreement.

India and New Zealand aim to finalize a comprehensive free trade agreement in 60 days, potentially increasing bilateral trade significantly. The agreement will focus on various sectors including ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vicarious Surgical (RBOT – Research Report), Alkermes (ALKS ...

Zealand Pharma has concluded enrolment for its global, randomised Phase IIb ZUPREME-1 trial, assessing petrelintide.

India and New Zealand have bolstered their ties by enhancing defence and security collaborations, emphasizing a free ...

PM Modi and visiting New Zealand Prime Minister Christopher Luxon held wide-ranging talks with a focus on boosting overall bilateral ties, especially in areas of trade, defence, education and ...

India and New Zealand on Monday (17 March) signed a major agreement to institutionalise their defence and security ...

India and New Zealand on Monday inked an ambitious pact to institutionalise defence ties and vowed to boost cooperation in ...

Your Excellency, Prime Minister Luxon, Delegates from both the countries, Friends from Media, Namaskar! Kia Ora!